Longitudinal Analysis of the Relationship Between Concomitant Anticholinergic Drug Use and Response to Donepezil in Mild-to-Moderate Alzheimer's Disease

被引：0
|
作者：
Bowles, Susan [1 ,3 ,4 ]
Weerasinghe, Swarna [2 ,3 ]
Rockwood, Kenneth [1 ]
Sketris, Ingrid [1 ,2 ,3 ]
机构：
[1] Dalhousie Univ, Div Geriatr Med, Dept Med, Halifax, NS, Canada
[2] Dalhousie Univ, Coll Pharm, Halifax, NS, Canada
[3] Dalhousie Univ, Dept Community Hlth & Epidemiol, Halifax, NS, Canada
[4] Capital Dist Hlth Author, Dept Pharm, Halifax, NS, Canada
来源：
CANADIAN JOURNAL OF HOSPITAL PHARMACY | 2008年 / 61卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：83 / 83
页数：1
相关论文
共 50 条
  • [1] Safety and efficacy of donepezil in African Americans with mild-to-moderate Alzheimer's disease
    Griffith, Patrick
    Lichtenberg, Peter
    Goldman, Robert
    Payne-Parrish, Jennifer
    [J]. JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2006, 98 (10) : 1590 - 1597
  • [2] Effectiveness of Donepezil in Reducing Clinical Worsening in Patients with Mild-to-Moderate Alzheimer's Disease
    Wilkinson, David
    Schindler, Rachel
    Schwam, Elias
    Waldemar, Gunhild
    Jones, Roy W.
    Gauthier, Serge
    Lopez, Oscar L.
    Cummings, Jeffrey
    Xu, Yikang
    Feldman, Howard H.
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2009, 28 (03) : 244 - 251
  • [3] Prediction of psychiatric response to donepezil in patients with mild to moderate Alzheimer's disease
    Tanaka, M
    Namiki, C
    Thuy, DHD
    Yoshida, H
    Kawasaki, K
    Hashikawa, K
    Fukuyama, H
    Kita, T
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2004, 225 (1-2) : 135 - 141
  • [4] Persistent use of Analgesic Medications in Mild-to-Moderate Alzheimer's Disease
    Gallini, Adeline
    Gardette, Virginie
    Vellas, Bruno
    Lapeyre-Mestre, Maryse
    Andrieu, Sandrine
    Brefel-Courbon, Christine
    [J]. DRUGS & AGING, 2013, 30 (06) : 439 - 445
  • [5] Persistent use of Analgesic Medications in Mild-to-Moderate Alzheimer’s Disease
    Adeline Gallini
    Virginie Gardette
    Bruno Vellas
    Maryse Lapeyre-Mestre
    Sandrine Andrieu
    Christine Brefel-Courbon
    [J]. Drugs & Aging, 2013, 30 : 439 - 445
  • [6] Biomarker Exposure-Response Analysis in Mild-To-Moderate Alzheimer's Disease Trials of Bapineuzumab
    Russu, Alberto
    Samtani, Mahesh N.
    Xu, Steven
    Adedokun, Omoniyi J.
    Lu, Ming
    Ito, Kaori
    Corrigan, Brian
    Raje, Sangeeta
    Liu, Enchi
    Brashear, H. Robert
    Styren, Scot
    Hu, Chuanpu
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2016, 53 (02) : 535 - 546
  • [7] Significant behavioral benefits with continued donepezil treatment in patients with mild-to-moderate Alzheimer's disease.
    Nunez, M
    Barcikowska, M
    Dautzenberg, P
    Heun, R
    Jakobsen, S
    Karageorgiou, C
    Triau, E
    Tury, F
    Qvitzau, S
    Richardson, S
    Xu, Y
    Schwam, E
    Schindler, R
    Johannsen, P
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (04) : S76 - S76
  • [8] Memantine in the treatment of mild-to-moderate Alzheimer's disease
    Cosman, Kelly M.
    Boyle, Llsa L.
    Porsteinsson, Anton P.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (02) : 203 - 214
  • [9] Solanezumab for the treatment of mild-to-moderate Alzheimer's disease
    Imbimbo, Bruno P.
    Ottonello, Simone
    Frisardi, Vincenza
    Solfrizzi, Vincenzo
    Greco, Antonio
    Seripa, Davide
    Pilotto, Alberto
    Panza, Francesco
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2012, 8 (02) : 135 - 149
  • [10] Cost-effectiveness analysis of donepezil for mild to moderate Alzheimer's disease in Taiwan
    Fuh, Jong-Ling
    Wang, Shuu-Jiun
    [J]. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2008, 23 (01) : 73 - 78
12345